Oxford Asset Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $683K | Buy |
|
|||||
|
2017
Q3 | $558K | Sell |
|
|||||
|
2017
Q2 | $674K | Buy |
|
|||||
|
2017
Q1 | $671K | Buy |
|
|||||
|
2016
Q4 | $526K | Buy |
|
|||||
|
2016
Q3 | $133K | Buy |
|
|||||
|
2016
Q2 | $60K | Buy |
|
|||||
|
2016
Q1 | $28K | Sell |
|
|||||
|
2015
Q4 | $230K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $28K | Sell |
|
|||||
|
2014
Q4 | $605K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $56K | Sell |
|
|||||
|
2014
Q1 | $366K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $70K | Buy |
|